Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic Mice.

Ben M Looney, Anna V Chernatynskaya, Michael J Clare-Salzler, Chang-Qing Xia

Abstract read

In one paragraph

Article in Journal of blood disorders & transfusion, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine.Molecular therapy oncolytics · 2022
Article
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?Frontiers in immunology · 2019
Review
Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.Frontiers in immunology · 2018
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ben M LooneyDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, USA.

Anna V ChernatynskayaDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, USA.

Michael J Clare-SalzlerDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, USA.

Chang-Qing XiaDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, USA.

Funding

Integrating beta cell antigenic epitopes into DC-based T1D immunotherapyR21DK080216 · NIDDK · UNIVERSITY OF FLORIDA · PI XIA, CHANGQING · 2009 to 2010

$403k

NIDDK NIH HHS R21 DK080216

6 · The paper itself

Abstract

Dendritic cells (DC) have been investigated as a cell-based therapy for Type 1 Diabetes (T1D). BM-DC expanded

Indexed as

Bone marrow-derived dendritic cellsFetal bovine serumNOD mouseSerum-free mediaType 1 diabetes

Identifiers

PMID26779386

DOI10.4172/2155-9864.1000206

PMCPMC4712959

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.